Synonym: 2,4,3′,5′-tetramethoxystilbene; 1-[(1E)-2-(3,5-dimethoxyphenyl)ethenyl]-2,4-dimethoxy-benzene; 2,3′,4,5′-Tetramethoxystilbene
CAS Number: 24144-92-1
Empirical Formula (Hill Notation): C18H20O4
Molecular Weight: 300.35
MDL Number: MFCD03428621
Linear Formula: C18H20O4
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: SMB00388-50MG
| assay |
≥98% (HPLC) |
| color |
white to yellow |
| form |
powder |
| InChI |
1S/C18H20O4/c1-19-15-8-7-14(18(12-15)22-4)6-5-13-9-16(20-2)11-17(10-13)21-3/h5-12H,1-4H3/b6-5+ |
| InChI key |
JDBCWSHYEQUBLW-AATRIKPKSA-N |
| Quality Level |
200  |
| SMILES string |
COC1=CC(OC)=CC=C1/C=C/C2=CC(OC)=CC(OC)=C2 |
| storage temp. |
−20°C |
| technique(s) |
HPLC: suitable |
| Biochem/physiol Actions: |
2,3′,4,5′-Tetramethoxystilbene, also known as TMS, is a selective and competitive inhibitor of cytochrome P450 1B. It is a synthetic trans-stilbene analog. TMS is an analog of resveratrol and is an anti-cancer agent. TMS is cytotoxic to gefitinib-resistant (G-R) non-small-cell lung cancer (NSCLC) cells. It binds to sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) and promotes apoptosis and autophagy. TMS is also a selective inhibitor of CYP1B1. |
| Packaging: |
10 mg in glass bottle |
| Packaging: |
50 mg in poly bottle |
| Symbol |
GHS07 |
| Signal word |
Warning |
| Hazard statements |
H302 |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
−20°C |
| UNSPSC |
85151701 |